Global Antifungal Drugs Market Size & Outlook, 2023-2030
Global antifungal drugs market, 2018-2030 (US$M)
Related Markets
Global antifungal drugs market highlights
- The global antifungal drugs market generated a revenue of USD 15,806.9 million in 2023 and is expected to reach USD 20,517.1 million by 2030.
- The market is expected to grow at a CAGR (2024 - 2030) of 3.8% by 2030.
- In terms of segment, azoles accounted for a revenue of USD 7,524.1 million in 2023.
- Echinocandins is the most lucrative drug class segment registering the fastest growth during the forecast period.
- In terms of region, North America was the largest revenue generating market in 2023.
- Country-wise, Spain is expected to register the highest CAGR from 2024 to 2030.
Global data book summary
| Market revenue in 2023 | USD 15,806.9 million |
| Market revenue in 2030 | USD 20,517.1 million |
| Growth rate | 3.8% (CAGR from 2023 to 2030) |
| Largest segment | Azoles |
| Fastest growing segment | Echinocandins |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Azoles, Echinocandins, Polyenes, Allylamines |
Other key industry trends
- In terms of revenue, the North America accounted for 40.9% of the global antifungal drugs market in 2023.
- By country, the U.S. is projected to lead the global market in terms of revenue in 2030.
- By country, Spain is the fastest growing regional market and is projected to reach USD 300.0 million by 2030.
Azoles was the largest segment with a revenue share of 47.6% in 2023. Horizon Databook has segmented the Global antifungal drugs market based on azoles, echinocandins, polyenes, allylamines covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing incidence of fungal infections is the key contributing factor expected to propel the growth of the antifungal drugs market over the forecast period. Fungal infections encompass both systemic and superficial infections including infection of the skin, eye, mouth, and vagina. Antifungal products with fungicidal activity are mostly used to treat a wide array of diseases, such as athlete's foot, fungal meningitis, and ringworm, caused by fungal agents.
Fungal diseases are a public health problem as they can affect any individual. However, there is severe threat of fungal infections to people with weak immune response such as patients with AIDS. There is a high possibility of development of opportunistic fungal infections in these patients.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Antifungal Drugs Market Scope
Antifungal Drugs Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Global antifungal drugs market size, by regions, 2018-2030 (US$M)
Top 10 countries: Antifungal drugs market size, 2023 (US$M)
Global antifungal drugs market share, by drug class, 2023 & 2030 (%, US$M)
Antifungal drugs market: Opportunity assessment by country
Global antifungal drugs market, by region, 2023 (US$M)
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
